Literature DB >> 11085513

Somatic von Hippel-Lindau gene mutations detected in sporadic endolymphatic sac tumors.

A O Vortmeyer1, S C Huang, C A Koch, L Governale, R D Dickerman, P E McKeever, E H Oldfield, Z Zhuang.   

Abstract

Endolymphatic sac tumors (ELSTs) occur sporadically or in association with an autosomal dominantly inherited tumor syndrome, von Hippel-Lindau (VHL) disease. In VHL disease, a germline mutation of the VHL tumor suppressor gene is inherited, and loss of function of the wild-type allele occurs through genetic deletion with subsequent development of neoplastic growth. Genetic alterations associated with sporadic ELSTs are less well understood. In this study, we used tissue microdissection to selectively analyze neoplastic cells from four sporadic ELSTs. In two cases, we detected somatic mutations involving VHL gene exons 1 and 2, respectively. Additionally, one of these cases revealed deletion of the VHL gene locus. Two cases did not reveal VHL gene mutation; one of these two cases showed VHL gene deletion. These results suggest that mutations and allelic deletions of the VHL tumor suppressor gene play a role in the tumorigenesis of sporadic ELSTs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11085513

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Adenomatous tumors of the middle ear and temporal bone: clinical, morphological and tumor biological characteristics of challenging neoplastic lesions.

Authors:  M Duderstadt; Christine Förster; H-J Welkoborsky; H Ostertag
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-08-24       Impact factor: 2.503

2.  Immunohistochemical Expression Pattern of Theragnostic Targets SSTR2 and PSMA in Endolymphatic Sac Tumors: A Single Institution Case Series.

Authors:  Muriel D Brada; Elisabeth J Rushing; David Bächinger; Loris Zoller; Irene A Burger; Martin W Hüllner; Holger Moch; Alexander Huber; Andreas H Eckhard; Niels J Rupp
Journal:  Head Neck Pathol       Date:  2022-05-11

3.  Tumors and pseudotumors of the endolymphatic sac.

Authors:  Rodney C Diaz; Esmael H Amjad; Eric W Sargent; Michael J Larouere; Wayne T Shaia
Journal:  Skull Base       Date:  2007-11

4.  Epidermal growth factor receptor as a novel molecular target for aggressive papillary tumors in the middle ear and temporal bone.

Authors:  Shigeru Kawabata; M Christine Hollander; Jeeva P Munasinghe; Lauren R Brinster; José R Mercado-Matos; Jie Li; Lucia Regales; William Pao; Pasi A Jänne; Kwok-Kin Wong; John A Butman; Russell R Lonser; Marlan R Hansen; Richard K Gurgel; Alexander O Vortmeyer; Phillip A Dennis
Journal:  Oncotarget       Date:  2015-05-10

5.  Case reports: old-timers and evergreens.

Authors:  C A Koch; T Fülöp
Journal:  J Med Case Rep       Date:  2018-11-27

6.  Expression of renal cell markers and detection of 3p loss links endolymphatic sac tumor to renal cell carcinoma and warrants careful evaluation to avoid diagnostic pitfalls.

Authors:  Rachel Jester; Iya Znoyko; Maria Garnovskaya; Joseph N Rozier; Ryan Kegl; Sunil Patel; Tuan Tran; Malak Abedalthagafi; Craig M Horbinski; Mary Richardson; Daynna J Wolff; Razvan Lapadat; William Moore; Fausto J Rodriguez; Jason Mull; Adriana Olar
Journal:  Acta Neuropathol Commun       Date:  2018-10-19       Impact factor: 7.801

7.  Endolymphatic sac tumor at the cerebellopontine angle: A case report and review of literature.

Authors:  Afnan Alkhotani; Babar Butt; Mohammad Khalid; Mohammad Binmahfoodh; Youssef Al-Said
Journal:  Int J Surg Case Rep       Date:  2019-04-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.